In a previous preliminary study we found that tissue samples from patients with large tubulovillous adenomas or adenocarcinomas had reduced Pms2 expression in cell nuclei at the bases of crypts (including the stem cell regions) near these tumors. Here, PMS2 is linked to adenocarcinoma.